WO2006005046A2 - Click chemistry route to triazole dendrimers - Google Patents

Click chemistry route to triazole dendrimers Download PDF

Info

Publication number
WO2006005046A2
WO2006005046A2 PCT/US2005/023718 US2005023718W WO2006005046A2 WO 2006005046 A2 WO2006005046 A2 WO 2006005046A2 US 2005023718 W US2005023718 W US 2005023718W WO 2006005046 A2 WO2006005046 A2 WO 2006005046A2
Authority
WO
WIPO (PCT)
Prior art keywords
dendron
generation
product
dendrimer
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/023718
Other languages
English (en)
French (fr)
Other versions
WO2006005046A3 (en
WO2006005046A9 (en
Inventor
Valery Fokin
Barry K. Sharpless
Peng Wu
Alina Feldman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Priority to JP2007519518A priority Critical patent/JP2008505224A/ja
Priority to CA002572063A priority patent/CA2572063A1/en
Priority to EP05764601A priority patent/EP1765910A4/en
Priority to AU2005260751A priority patent/AU2005260751A1/en
Priority to US11/631,081 priority patent/US20090069561A1/en
Publication of WO2006005046A2 publication Critical patent/WO2006005046A2/en
Publication of WO2006005046A9 publication Critical patent/WO2006005046A9/en
Publication of WO2006005046A3 publication Critical patent/WO2006005046A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/05Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002Dendritic macromolecules
    • C08G83/003Dendrimers

Definitions

  • the invention relates to dendrimers and to methods for making dendrimers. More particularly, the invention relates to the use of click chemistry for synthesizing triazole dendrimers.
  • Dendrimers have many uses. For example, the recently discovered ability of polydentate 1 ,4-disubstituted 1 ,2,3-triazoles ligands to stabilize Cu(I) species even in aqueous aerobic conditions (T. R. Chan, et al. Org. Lett. Submitted), has already proven crucial in biological applications (Q. Wang, et al. J. Am. Chem. Soc. 2003, 125, 3192-3193; A. E. Speers, et al. J. Am. Chem. Soc. 2003, 725, 4686-4687; A. J. Link, D. A. Tirrell J. Am. Chem. Soc.
  • Triazole dendrimers can be employed for this purpose.
  • dendrimers are employable for making porous materials, i.e., the dendrimers are mixed with a matrix material, the matrix material is solidified, and the dendrimers are vaporized.
  • dendrimers of uniform size must be employed. Unfortunately, prior to the present disclosure, it was not practical to make dendrimers having a precisely uniform size, i.e., substantially all dendrimers having the same size.
  • a highly efficient route for the production of triazole-based dendrimers employs click chemistry. This route benefits from the unprecedented reliability of the Cu(l)-catalyzed ligation of terminal acetylenes and azides.
  • the chemistry is highly regioselective, resulting in 1 ,4-disubstituted triazoles.
  • a variety of functional groups are compatible with the process and the only major byproduct formed in the reaction is NaCI. All second generation and some third generation dendrons were directly isolated as pure solids (i.e. no chromatographic separations), meeting the requirements for large scale applications.
  • One aspect of the invention is directed to a process for producing a product dendron having a single azide group.
  • the process comprises a first step wherein "n" organic azide molecules are reacted with an AB n molecule.
  • the AB n molecule has "n" terminal acetylene functionalities and one halomethyl group, where "n” is two or greater.
  • the reaction occurs in the presence of sufficient copper catalyst to insure complete reaction for producing a product molecule having "n " triazoles and one halomethyl group.
  • the product molecule of the first step is reacted with sufficient sodium azide in an organic/aqueous solvent mixture at a temperature high enough to give complete or nearly complete displacement of the chloride from the halomethyl group for producing the product dendron having a single azide group.
  • the product dendron is a first generation dendron.
  • Preferred organic azides are selected from the group represented by the following structures:
  • n is two.
  • Preferred AB n molecules are selected from the group represented by the following structures:
  • the product dendron is a second generation dendron and each of the "n" organic azide molecules is a first generation dendron. In this instance, the first generation dendron may also be made by the process of the invention or not.
  • the product dendron is a third generation dendron and each of the "n" organic azide molecules is a second generation dendron. In this instance, the second generation dendron may also be made by the process of the invention or not.
  • the product dendron is a fourth generation dendron and each of the "n" organic azide molecules is a third generation dendron. In this instance, the third generation dendron may also be made by the process of the invention or not.
  • Another aspect of the invention is directed to a process for producing a triazole containing dendrimer.
  • the process comprises the step of reacting two or more dendrons, each dendron possessing a single azide functionality, with a polyacetylene core compound, the polyacetylene core compound containing two or more terminal acetylene groups, in a suitable solvent and in the presence of catalytic quantity of copper(l) species for catalyzing a triazole formation reaction for forming the dendrimer.
  • the process may include the further step of washing the product of the first step with sufficient aqueous ammonium hydroxide/citrate solution to remove copper species that may be bound to triazole moieties of the dendrimer.
  • the polyacetylene core is selected from the group represented by the following structures:
  • This process may be employed for making a first, second, third, or fourth generation dendrimer wherein the dendron is first, second, third, or fourth generation dendron, respectively.
  • Another aspect of the invention is directed to the first, second, third, and fourth dendrimers made according to the above processes.
  • Another aspect of the invention is directed to a trifunctional reagent represented by the following formula:
  • X is a diradical selected from the group consisting of -O- and -S-; R is a radical selected from the group consisting of -Cl and -Br; n is 1-10; and m is 1-10.
  • a preferred embodiment of this aspect of the invention may be represented by the following formula:
  • Another aspect of the invention is directed to a trifunctional reagent represented by the following formula:
  • R is a radical selected from the group consisting of -Cl and -Br; n is 1-10; and m is 1-10.
  • R is a radical selected from the group consisting of -Cl and -Br; n is 1-10; and m is 1-10.
  • Another aspect of the invention is directed to a trifunctional reagent represented by the following formula:
  • R is a radical selected from the group consisting of -Cl and -Br; n is 1-10; and m is 1-10.
  • R is a radical selected from the group consisting of -Cl and -Br; n is 1-10; and m is 1-10.
  • Another aspect of the invention is directed to a core molecule represented by the following formula:
  • n 1-10.
  • Figure 1 illustrates an example of a large dendrimer that can be prepared by the method outlined.
  • Figure 2 illustrates the copper(l)-catalyzed synthesis of 1 ,4-disubstituted
  • Figure 3 illustrates the reaction sequence by which the individual branches or dendrons, were constructed, starting from the "outside" of the molecule.
  • Figure 4 illustrates three structures that were chosen for the AB 2 monomers.
  • FIG. 5 illustrates the different monoazides which are used for the chain ends.
  • Figure 6 illustrates an NMR spectrum of the product b/s-triazole.
  • Figure 7 illustrates the GPC traces for the crude reaction products, MEE-B-[G-4]-N 3 (9d), MEE-B-[G-3]-N 3 (6d), and MEE-B-[G-2]-N 3 (4d), obtained by dendritic growth from the benzyl ether monomer 11 , and the azido di(ethylene glycol) derivative 19.
  • Figure 8 illustrates the structures of the polyacetylene cores to which the dendrons were anchored.
  • Figure 9 illustrates a representative example of a dendrimer that is obtained by coupling a third generation dendron to a triacetylene core.
  • Figure 10 illustrates a MALDl-TOF mass spectrum of dendrimer 7a.
  • the primary chlorides were converted to the corresponding azides by reaction with 1.5 equivalents of sodium azide in acetone/water mixture, which was equally facile and typically resulted in yields of more than 95% with the only byproduct being NaCI.
  • the dendrons were then 'grown 1 via the reaction of the resulting azides with the original monomers 11, 12 or 13. All second generation dendrons were isolated as pure white solids by simple filtration or aqueous workup, producing the second generation azide dendrons in isolated yields exceeding 90%.
  • amide monomer 12 with terf-butyl azide 17 at the periphery as well as the benzyl ether monomer 11 with azide 19 were propagated to the fourth generation.
  • Monomer 12 with the azide 16 and 19 at the periphery was propagated to the third generation, respectively.
  • slight modification of reaction conditions led to the same degree of efficiency and near quantitative yields.
  • benzyl terminated dendrimers prepared from 14 and 11 were found to be insoluble in 1 :1 H 2 O/THF solutions at second generation, resulting in no reaction.
  • conversion of the chloromethyl group to the azide group was unsuccessful with aqueous sodium azide.
  • Figure 1 shows an example of a large dendrimer that can be prepared by the method outlined.
  • the different R groups shown allow for different solubilities of the resultant dendrimer.
  • Figure 2 shows the copper(l)-catalyzed synthesis of 1 ,4-disubstituted 1 ,2,3-triazoles.
  • the copper(l) is obtained by in situ reduction of the copper(ll) species, here obtained from copper sulfate.
  • the reaction is run at ambient temperature in a water/alcohol solvent mixture to give nearly quantitative yields of the 1 ,2,3-triazole product.
  • Figures 3A and 3B show the reaction sequence by which the individual branches or dendrons, were constructed, starting from the "outside” of the molecule. These are then coupled to a multivalent centerpiece or “core” in the last step.
  • the internal repeat units are "X” and the chain end groups are "R.”
  • Figure 4 shows three structures that were chosen for the AB 2 monomers. These were based on terminal acetylenes and alkyl halide functionalities. The structural feature, in addition to the diacetylene, that was retained between the three structures 11, 12, and 13 was the chloromethyl group. The reaction of dendritic fragments containing one chloromethyl group with sodium azide would lead to the quantitative formation of the azidomethyl group which would then be coupled with 11 , 12 or 13 to give the next generation dendron.
  • Figure 5 shows the different monoazides which are used for the chain ends.
  • the non-reactive groups have an aryl, alkyl and methoxyethoxy ends and the reactive end groups have carboxylic acid, benzyl alcohol and protected primary amine functionalities.
  • Figure 6 is an NMR spectrum of the product b/s-triazole.
  • the spectrum shows the complete lack of any regioisomers in the product as would be expected from a thermal cycloaddition reaction.
  • the ratio of integration for protons f and c is 2:1 which shows that only one regioisomer is formed in the cycloaddition.
  • the presence of two signals for both f and c protons is due to the different magnetic environments in the amide bond rotomers.
  • Figure 7 shows the GPC traces for the crude reaction products, MEE-B-
  • Figure 8 shows the structures of the polyacetylene cores to which the dendrons were anchored.
  • Figure 9 is a representative example of a dendrimer that is obtained by coupling a third generation dendron to a triacetylene core.
  • Figure 10 is a MALDI-TOF mass spectrum of dendrimer 7a. This time- of-flight mass spectrum was part of the proof of purity of this product.
  • Permeation Chromatography was performed in tetrahydrofuran (THF) on a Waters chromatograph equipped with four 5- ⁇ m Waters columns (300 mm x 7.7 mm) connected in series with increasing pore size (two mixed B, 10 3 A, 10 5 A).
  • a Waters 410 differential refractometer and a 996 photodiode array detector were employed. The molecular weights of the polymers were calculated relative to linear polystyrene standards.
  • the modulated differential scanning calorimetry (MDSC) measurements were performed with the TA Instruments DSC 2920 and a ramp rate of 4 degrees per minute.
  • R-X-[G-n]-Y where R describes the functional groups at periphery, Bn for benzyl , Boc for ferf-butyl ethylcarbamate, tBu for te/f-butyl, MEE for (2-methoxyethoxy)ethane;
  • X describes internal repeat units, B for 1 , 3 dioxybenzene, F for formamide, S for benzenesulfonamide;
  • n is the number for generations;
  • Y describes functional group at the focal point, either chloride, Cl, or azide, N 3 .
  • the white cloudy suspension was diluted with 10 ml H 2 O and 1 ml concentrated NH 4 OH, stirred for 10 minutes, and then filtered. The resulting filtrate, a white powder, was washed 3 times with 10 ml H 2 O and dried to obtain the pure Bn-F-[G-I]-CI 1b. (737 mg, 96% yield).
  • MALDI-TOF 1076 (MNa + ), PDI: 1.01.
  • the reaction mixture is diluted with 5 ml H 2 O and 1 ml concentrated NH 4 OH/citrate buffer, stirred for 2 minutes and extracted 3 times with 30 ml portions of CHCI 3 .
  • the organic layer is washed with brine, dried over NaSO 4 , and evaporated to yield a while solid, which is then purified by prep-HPLC (pump flow gradient settings- solvent CH 3 CN/H 2 O; flowing rate: 6.5 ml/min, 0 min, 29% CH 3 CN; 2 min, 58 % CH 3 CN, 30 min 80% CH 3 CN) to give pure dendrimer 7a 150mg, 90% yield.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PCT/US2005/023718 2004-06-30 2005-06-30 Click chemistry route to triazole dendrimers Ceased WO2006005046A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2007519518A JP2008505224A (ja) 2004-06-30 2005-06-30 トリアゾールデンドリマーへのクリックケミストリールート
CA002572063A CA2572063A1 (en) 2004-06-30 2005-06-30 Click chemistry route to triazole dendrimers
EP05764601A EP1765910A4 (en) 2004-06-30 2005-06-30 HIGH AFFINITY CHEMISTRY FOR THE PRODUCTION OF TRIAZOLE DENDRIMERES
AU2005260751A AU2005260751A1 (en) 2004-06-30 2005-06-30 Click chemistry route to triazole dendrimers
US11/631,081 US20090069561A1 (en) 2004-06-30 2005-06-30 Click chemistry route to triazole dendrimers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58481704P 2004-06-30 2004-06-30
US60/584,817 2004-06-30

Publications (3)

Publication Number Publication Date
WO2006005046A2 true WO2006005046A2 (en) 2006-01-12
WO2006005046A9 WO2006005046A9 (en) 2006-03-09
WO2006005046A3 WO2006005046A3 (en) 2006-11-30

Family

ID=35783400

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/023718 Ceased WO2006005046A2 (en) 2004-06-30 2005-06-30 Click chemistry route to triazole dendrimers

Country Status (7)

Country Link
US (1) US20090069561A1 (enExample)
EP (1) EP1765910A4 (enExample)
JP (1) JP2008505224A (enExample)
CN (1) CN101006119A (enExample)
AU (1) AU2005260751A1 (enExample)
CA (1) CA2572063A1 (enExample)
WO (1) WO2006005046A2 (enExample)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006135233A1 (en) * 2005-06-17 2006-12-21 Universiteit Utrecht Holding B.V. Dendrimers multivalently substituted with active groups
WO2008141357A1 (en) * 2007-04-26 2008-11-27 The University Of Queensland Dendritic molecules
EP1910497A4 (en) * 2005-07-14 2009-08-12 Scripps Research Inst COMPOSITIONS AND METHOD FOR COUPLING MULTIPLE COMPOUNDS TO A SCAFFOLDING
US8034396B2 (en) 2008-04-01 2011-10-11 Tyco Healthcare Group Lp Bioadhesive composition formed using click chemistry
US8071718B2 (en) 2004-12-22 2011-12-06 General Electric Company Selective radiolabeling of biomolecules
US8512728B2 (en) 2009-02-21 2013-08-20 Sofradim Production Method of forming a medical device on biological tissue
US8535477B2 (en) 2009-02-21 2013-09-17 Sofradim Production Medical devices incorporating functional adhesives
US8663689B2 (en) 2009-02-21 2014-03-04 Sofradim Production Functionalized adhesive medical gel
WO2014057201A1 (fr) * 2012-10-08 2014-04-17 Commissariat A L'energie Atomique Et Aux Energies Alternatives Nouveaux azotures, procédés de fabrication et leurs applications
US8865857B2 (en) 2010-07-01 2014-10-21 Sofradim Production Medical device with predefined activated cellular integration
US8877170B2 (en) 2009-02-21 2014-11-04 Sofradim Production Medical device with inflammatory response-reducing coating
US8968733B2 (en) 2009-02-21 2015-03-03 Sofradim Production Functionalized surgical adhesives
US9247931B2 (en) 2010-06-29 2016-02-02 Covidien Lp Microwave-powered reactor and method for in situ forming implants
WO2016154029A1 (en) * 2015-03-20 2016-09-29 Massachusetts Institute Of Technology Formation of macromolecules using iterative growth and related compounds
US9775928B2 (en) 2013-06-18 2017-10-03 Covidien Lp Adhesive barbed filament
WO2019145025A1 (en) * 2018-01-24 2019-08-01 Ecole Polytechnique Federale De Lausanne (Epfl) Covalent polymer network semiconducting thin-films and method for producing thereof

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208243B2 (en) * 2004-12-01 2007-04-24 Toyota Technical Center Usa, Inc. Proton exchange membranes using cycloaddition reaction between azide and alkyne containing components
CN101283046A (zh) * 2005-07-18 2008-10-08 斯克里普斯研究学院 制备两亲性树枝状聚合物的方法
US20090306310A1 (en) * 2005-07-18 2009-12-10 The Scripps Research Institute Method of using click chemistry to functionalize dendrimers
US20070060658A1 (en) * 2005-08-31 2007-03-15 Diaz David D Stabilization of organogels and hydrogels by azide-alkyne [3+2] cycloaddition
US8927682B2 (en) * 2007-08-24 2015-01-06 Board Of Trustees Of Michigan State University Functionalization of polyglycolides by “click” chemistry
US8394914B2 (en) * 2007-08-24 2013-03-12 Board Of Trustees Of Michigan State University Functional polyglycolide nanoparticles derived from unimolecular micelles
US8252834B2 (en) 2008-03-12 2012-08-28 The Regents Of The University Of Michigan Dendrimer conjugates
JP5093680B2 (ja) * 2008-06-26 2012-12-12 独立行政法人産業技術総合研究所 ビス四級アンモニウム塩コア型デンドリマー
WO2010005127A2 (en) * 2008-07-09 2010-01-14 Postech Academy-Industry Foundation Heterogeneous copper nanocatalyst and manufacturing methods thereof
WO2010039861A2 (en) 2008-09-30 2010-04-08 The Regents Of The University Of Michigan Dendrimer conjugates
WO2010054321A2 (en) 2008-11-07 2010-05-14 The Regents Of The University Of Michigan Methods of treating autoimmune disorders and/or inflammatory disorders
WO2010095052A2 (en) 2009-02-21 2010-08-26 Sofradim Production Compounds and medical devices activated with solvophobic linkers
EP2398850B1 (en) 2009-02-21 2018-08-22 Sofradim Production Medical devices with an activated coating
EP2398524B1 (en) 2009-02-21 2017-07-12 Covidien LP Medical devices having activated surfaces
AU2010215931A1 (en) 2009-02-21 2011-10-13 Covidien Lp Medical devices having activated surfaces
WO2010095055A1 (en) 2009-02-21 2010-08-26 Sofradim Production Crosslinked fibers and method of making same using uv radiation
WO2010095053A2 (en) 2009-02-21 2010-08-26 Sofradim Production Apparatus and method of reaching polymers by exposure to uv radiation to produce injectable medical devices
US8648144B2 (en) 2009-02-21 2014-02-11 Sofradim Production Crosslinked fibers and method of making same by extrusion
AU2010215194A1 (en) 2009-02-21 2011-10-13 Sofradim Production Apparatus and method of reacting polymers passing through metal ion chelated resin matrix to produce injectable medical devices
EP2398845B1 (en) 2009-02-21 2017-12-13 Sofradim Production Amphiphilic compounds and self-assembling compositions made therefrom
US20120232225A1 (en) * 2009-08-26 2012-09-13 The Regents Of The University Of Michigan Synthesis and isolation of dendrimer systems
CA2777682C (en) 2009-10-13 2015-02-24 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
US8912323B2 (en) 2009-10-30 2014-12-16 The Regents Of The University Of Michigan Multifunctional small molecules
EP2550031B1 (en) 2010-03-25 2015-08-19 Sofradim Production Medical devices incorporating functional adhesives
AU2011231246B2 (en) 2010-03-25 2015-05-21 Sofradim Production Surgical fasteners and methods for sealing wounds
WO2012014080A2 (en) 2010-07-27 2012-02-02 Sofradim Production Polymeric fibers having tissue reactive members
CN102153748B (zh) * 2010-12-07 2012-11-07 浙江大学 具有聚集诱导发光性能的超支化聚三唑及其制备方法和应用
US9402911B2 (en) 2011-12-08 2016-08-02 The Regents Of The University Of Michigan Multifunctional small molecules
CN102585220B (zh) * 2012-01-16 2013-07-24 浙江大学 一种超支化聚三唑甲酸酯及其制备方法和应用
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
CN105771942B (zh) * 2014-12-26 2018-06-29 中国科学院大连化学物理研究所 一种磁性纳米材料及其制备与应用
CN114262435B (zh) * 2021-12-20 2023-02-14 大连理工大学 一种基于炔烃、胺、叠氮的三组分聚合制备手性聚甲胺基三唑的方法及应用
WO2025059162A1 (en) 2023-09-11 2025-03-20 Dana-Farber Cancer Institute, Inc. Car-engager containing il-2 variants to enhance the functionality of car t cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2864683A (en) * 1953-10-30 1958-12-16 Monsanto Chemicals Selective method of inhibiting preemergent growth of grasses
JP3023053B2 (ja) * 1993-07-07 2000-03-21 ミネソタ マイニング アンド マニュファクチャリング カンパニー ジポラロフィルで誘導したアジドポリマー
WO1998030575A1 (en) * 1997-01-08 1998-07-16 Proligo Llc Bioconjugation of macromolecules
ATE469135T1 (de) * 2002-05-30 2010-06-15 Scripps Research Inst Kupferkatalysierte ligierung von aziden und acetylenen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of EP1765910A4 *

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071718B2 (en) 2004-12-22 2011-12-06 General Electric Company Selective radiolabeling of biomolecules
WO2006135233A1 (en) * 2005-06-17 2006-12-21 Universiteit Utrecht Holding B.V. Dendrimers multivalently substituted with active groups
EP1910497A4 (en) * 2005-07-14 2009-08-12 Scripps Research Inst COMPOSITIONS AND METHOD FOR COUPLING MULTIPLE COMPOUNDS TO A SCAFFOLDING
EP2452936A1 (en) * 2005-07-14 2012-05-16 The Scripps Research Institute Compositions and methods for coupling a plurality of compounds to a scaffold
WO2008141357A1 (en) * 2007-04-26 2008-11-27 The University Of Queensland Dendritic molecules
US8034396B2 (en) 2008-04-01 2011-10-11 Tyco Healthcare Group Lp Bioadhesive composition formed using click chemistry
US8663689B2 (en) 2009-02-21 2014-03-04 Sofradim Production Functionalized adhesive medical gel
US8535477B2 (en) 2009-02-21 2013-09-17 Sofradim Production Medical devices incorporating functional adhesives
US8512728B2 (en) 2009-02-21 2013-08-20 Sofradim Production Method of forming a medical device on biological tissue
US8877170B2 (en) 2009-02-21 2014-11-04 Sofradim Production Medical device with inflammatory response-reducing coating
US8968733B2 (en) 2009-02-21 2015-03-03 Sofradim Production Functionalized surgical adhesives
US9510810B2 (en) 2009-02-21 2016-12-06 Sofradim Production Medical devices incorporating functional adhesives
US9247931B2 (en) 2010-06-29 2016-02-02 Covidien Lp Microwave-powered reactor and method for in situ forming implants
US8865857B2 (en) 2010-07-01 2014-10-21 Sofradim Production Medical device with predefined activated cellular integration
WO2014057201A1 (fr) * 2012-10-08 2014-04-17 Commissariat A L'energie Atomique Et Aux Energies Alternatives Nouveaux azotures, procédés de fabrication et leurs applications
US9775928B2 (en) 2013-06-18 2017-10-03 Covidien Lp Adhesive barbed filament
WO2016154029A1 (en) * 2015-03-20 2016-09-29 Massachusetts Institute Of Technology Formation of macromolecules using iterative growth and related compounds
US10125124B2 (en) 2015-03-20 2018-11-13 Massachusetts Institute Of Technology Formation of macromolecules using iterative growth and related compounds
WO2019145025A1 (en) * 2018-01-24 2019-08-01 Ecole Polytechnique Federale De Lausanne (Epfl) Covalent polymer network semiconducting thin-films and method for producing thereof

Also Published As

Publication number Publication date
JP2008505224A (ja) 2008-02-21
WO2006005046A3 (en) 2006-11-30
US20090069561A1 (en) 2009-03-12
EP1765910A4 (en) 2009-12-30
WO2006005046A9 (en) 2006-03-09
CA2572063A1 (en) 2006-01-12
AU2005260751A1 (en) 2006-01-12
CN101006119A (zh) 2007-07-25
EP1765910A2 (en) 2007-03-28

Similar Documents

Publication Publication Date Title
EP1765910A2 (en) Click chemistry route to triazole dendrimers
CN103649102B (zh) 包含二芳基硫化物骨架的对光不稳定的保护基团
JP2002167368A (ja) アルキル置換デンドリマーおよびその製造法
JPH0215533B2 (enExample)
CN110475801A (zh) 在末端具有多个羟基的聚氧乙烯衍生物的制造方法
Voit et al. Perfectly branched polyamide dendrons based on 5-(2-aminoethoxy)-isophthalic acid
KR20070032349A (ko) 트리아졸 덴드리머에 대한 클릭 화학 경로
US5869579A (en) Solid phase preparation of amines
Koç et al. Syntheses of new polyamine dendrimer units via a tandem hydroformylation/reductive amination sequences
CN101121708B (zh) 奥沙碘铵及其类似物的合成方法
JP2008531642A (ja) 薬学活性化合物イルベサルタンおよびその合成中間体を得る方法
JP3031036B2 (ja) 含フッ素芳香族ジアミン化合物、アミノ基が保護された含フッ素ジアミン化合物及びそれらの製造法
CN102325823B (zh) 得到改性聚乙二醇中间体的合成
Howarth et al. Synthesis of N-propynyl analogues of peptide nucleic acid (PNA) monomers and their use in the click reaction to prepare N-functionalized PNAs
CN119059990B (zh) 1-氨基甲酸叔丁酯哌嗪的制备方法
HASAN et al. Synthesis and Identification of New Nitrogen Rich Polymers Based on Sulfa Drug Derivatives.
CA2782701A1 (fr) Procede de preparation d'un derive de combretastatine
KR100800048B1 (ko) 아지드기를 가진 덴드론 및 그 제조방법
JP2004137422A (ja) ポリエーテル誘導体及びその製造方法
JP4348800B2 (ja) 新規なカルボキシル基含有アゾアミド化合物
JP4385436B2 (ja) 新規なアゾアミド化合物
JP2002167370A (ja) アルキルアゾベンゼン置換デンドリマーおよびその製造法
CN118108697A (zh) 一种结晶性螺环亚甲基碳酸酯衍生物及其制备方法和应用
WO2025183111A1 (ja) クリック反応素子aocn誘導体又はその塩
WO2021162070A1 (ja) 核酸製造用モノマーの製造方法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 6/10 AND 10/10, DRAWINGS, REPLACED BY NEW PAGES 6/10 AND 10/10; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2572063

Country of ref document: CA

Ref document number: 2005260751

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2007519518

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2005764601

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2005260751

Country of ref document: AU

Date of ref document: 20050630

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005260751

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020077002395

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 200580028487.3

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 1020077002395

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2005764601

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11631081

Country of ref document: US